Dr. Rebecca S. Lavelle, MD

Dr. Lavelle practices at Blount Memorial Physician Group, Inc. in Maryville, Tennessee.

Dr. Lavelle's NPI, 1104099662, was assigned on April 4, 2008. Dr. Lavelle graduated from Michigan State University College of Human Medicine in 2008. Dr. Lavelle holds Tennessee license MD0000053291.

Dr. Lavelle's primary practice is Blount Memorial Physician Group, Inc., at 103 W Broadway Ave, Maryville, TN 37801 in Blount County. The practice phone is (865) 984-3864.

Dr. Lavelle's primary practice is Blount Memorial Physician Group, Inc. in Maryville, Tennessee. Dr. Lavelle is also affiliated with Prisma Health Blount Memorial Hospital. The medical group on file is Blount Memorial Physicians Group. Dmand AI also links Dr. Lavelle to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lavelle practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lavelle's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lavelle is licensed in Tennessee.

CMS data shows 7,825 Medicare services from Dr. Lavelle across 17 procedure codes in 2024, for 412 Medicare patients. Medicare paid $123,040 for them. Every service was in an office.

CMS counts 412 Medicare patients who saw Dr. Lavelle in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lavelle's median patient age at 72, with 99% women.

In 2024, Dr. Lavelle wrote 3,284 Medicare Part D claims for 728 patients. 69% of them were for generic drugs. CMS names the drug for 3,168 of them, across 28 drugs with 11 or more claims each, at $864,019 in total drug cost. In 2023, CMS named 2,748 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Lavelle for performance year 2024, reported as part of a group. Dr. Lavelle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lavelle as offering telehealth.

Dmand AI links 10 papers to Dr. Lavelle, published from 2010 to 2017. 2015 was the busiest year, with 5. The most frequent topics are Urinary Bladder, Overactive and Urodynamics. Dr. Lavelle has published most often in Neurourol Urodyn. Dr. Lavelle's most frequent co-authors are Louise A. Gliga, MD, Gary Evan Lemack, MD and Philippe E. Zimmern, MD.

CMS Open Payments shows 370 general payments to Dr. Lavelle from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Axonics, Inc. paid the most, $2,329.

Dr. Lavelle graduated from Michigan State University College of Human Medicine in 2008.